How Big is the Oncology Diagnostics Market | Manufacturers and Suppliers 2025

What is the size of Oncology Diagnostics Market?

The primary growth drivers are the increase in demand for early cancer detection, the increase in adoption of less invasive diagnostic procedures, and developments in technologies around biomarker analysis that improve accuracy and decrease diagnostic turnaround time.

Growth Factors for Oncology Diagnostics Industry

• Increasing number of cancer cases necessitates better diagnostics.
• Liquid biopsy applications expanding to allow for real-time disease monitoring.
• Increasing use of AI and machine learning in pathology, imaging, and diagnostics.
• Increasing use of molecular diagnostics in personalized treatment planning.
• Expansion of oncology diagnostics services in emerging healthcare markets.

Oncology Diagnostics Market Trends

The Oncology Diagnostics Market trends highlight a dynamic transformation in cancer detection and monitoring, with a strong focus on accuracy, speed, and patient comfort. These trends reflect a convergence of healthcare innovations and technology-driven methods designed to improve diagnosis and offer more personalized treatment. 

Among the several trends is an acceleration of next-generation sequencing for broad genomic profiling, along with the expansion of companion diagnostics. Liquid biopsy is also expanding for more non-invasive monitoring. Digital pathology and AI-driven imaging platforms are also leading to more efficient workflows for clinicians and laboratories.

Emerging Developments in the Oncology Diagnostics Market

The Oncology Diagnostics Market developments underscore a strategic shift toward precision medicine and decentralized diagnostic capabilities. Growing collaborations between diagnostic companies and pharmaceutical companies are creating companion tests with a target scope to meet changing cancer therapies. 

In addition, the increased number of portable diagnostic devices entering the market, the inclusion of cloud-based reporting systems, and the increased speed of approval for new assays are facilitating quicker time to market. Investing R&D into multi-cancer early detection tests will continue to provide fluctuation into an evolving competitive landscape.

List of Leading Companies in the Oncology Diagnostics Market

Below is a comprehensive list of the leading market players driving growth in this sector:

1. F. Hoffmann-La Roche Ltd

Roche offers advanced oncology diagnostic tests, including tissue-based, molecular, and companion diagnostics, enabling precise cancer detection and personalized treatment planning.

2. Siemens Healthineers AG

Siemens Healthineers develops innovative imaging and molecular diagnostic solutions for cancer detection, enhancing early diagnosis, treatment monitoring, and clinical decision-making.

3. Thermo Fisher Scientific Inc.

Thermo Fisher provides oncology diagnostic tools including next-generation sequencing, PCR assays, and biomarker analysis to advance cancer research and patient care.

4. Illumina, Inc.

Illumina specializes in genomic sequencing technologies for oncology diagnostics, enabling accurate cancer profiling and personalized therapy selection.

5. Agilent Technologies, Inc.

Agilent offers pathology solutions, biomarker testing, and molecular diagnostics for cancer detection, aiding in early intervention and targeted treatment development.

6. Abbott Laboratories

Abbott provides oncology diagnostic assays, immunohistochemistry tests, and molecular diagnostics, supporting accurate cancer detection and treatment planning.

7. QIAGEN N.V.

QIAGEN develops sample-to-insight molecular diagnostics for cancer, including liquid biopsy solutions and companion diagnostic partnerships.

8. GE HealthCare Technologies Inc.

GE HealthCare delivers advanced imaging technologies and AI-driven oncology diagnostic tools, enhancing cancer detection accuracy and treatment monitoring.

9. Bio-Rad Laboratories, Inc.

Bio-Rad offers oncology diagnostic reagents, PCR-based assays, and genetic testing solutions to support cancer research and clinical diagnostics.

10. Myriad Genetics, Inc.

Myriad Genetics provides genetic and genomic tests for cancer risk assessment, diagnosis, and treatment guidance, focusing on hereditary cancers.

How Big is the Oncology Diagnostics Market 2025: FAQs